Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Encephalitis, Tick-Borne”

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06859619
What this trial is testing

Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases

Who this might be right for
LeishmaniasisLeptospirosisBrucellosis+15 more
University Hospital, Montpellier 183
Large-scale testing (Phase 3)Looking for participantsNCT07584525
What this trial is testing

Dexamethasone in Tick-borne Encephalitis

Who this might be right for
Tick-Borne Encephalitis
University Medical Centre Ljubljana 200
Large-scale testing (Phase 3)Study completedNCT04648241
What this trial is testing

Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older

Who this might be right for
Tick-Borne Encephalitis
Pfizer 165
Testing effectiveness (Phase 2)Study completedNCT00161850
What this trial is testing

FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer 615
Not applicableUnknownNCT02463942
What this trial is testing

Tick-borne Encephalitis and Positive Borrelial Antibodies

Who this might be right for
Tick-borne Encephalitis
University Medical Centre Ljubljana 100
Not applicableUnknownNCT00941590
What this trial is testing

Postencephalitic Symptoms After Tick Borne Encephalitis

Who this might be right for
Central European Encephalitis
University Medical Centre Ljubljana 200
Large-scale testing (Phase 3)Study completedNCT02318069
What this trial is testing

New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Who this might be right for
Tick-borne Encephalitis
Sormland County Council, Sweden 250
Post-approval studies (Phase 4)UnknownNCT04017052
What this trial is testing

Application of a TBE-Vaccine in Obese Persons

Who this might be right for
Tick Borne Encephalitis
Medical University of Vienna 73
Post-approval studies (Phase 4)Study completedNCT00452621
What this trial is testing

Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years

Who this might be right for
Encephalitis, Tick-Borne
Novartis 235
Early research (Phase 1)Not Yet RecruitingNCT07377253
What this trial is testing

First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers.

Who this might be right for
The Tick-borne Encephalitis Virus (TBEV)
Giuseppe Pantaleo 18
Not applicableStudy completedNCT05941546
What this trial is testing

Tick-borne Encephalitis Virus Research in Limousin

Who this might be right for
Tick-borne Encephalitis
University Hospital, Limoges 878
Large-scale testing (Phase 3)Study completedNCT00161863
What this trial is testing

Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

Who this might be right for
Tick-borne Encephalitis
Pfizer
Post-approval studies (Phase 4)Study completedNCT00804219
What this trial is testing

Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination

Who this might be right for
Tick-borne Encephalitis
Medical University of Vienna 67
Post-approval studies (Phase 4)Study completedNCT01562444
What this trial is testing

Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules

Who this might be right for
Tick Borne EncephalitisVirus Diseases
GlaxoSmithKline 206
Testing effectiveness (Phase 2)Study completedNCT00161889
What this trial is testing

FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer 615
Large-scale testing (Phase 3)Study completedNCT00161746
What this trial is testing

Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Testing effectiveness (Phase 2)Study completedNCT01991067
What this trial is testing

Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients

Who this might be right for
Tick Borne Encephalitis
Medical University of Vienna 34
Post-approval studies (Phase 4)Study completedNCT00161954
What this trial is testing

Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Large-scale testing (Phase 3)Study completedNCT00161876
What this trial is testing

FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years

Who this might be right for
Encephalitis, Tick-borne
Pfizer 3,973
Post-approval studies (Phase 4)Study completedNCT03294135
What this trial is testing

The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine

Who this might be right for
Virus Diseases
GlaxoSmithKline 194
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation